The Sword of Damocles is striking down, with extreme force, upon the heads of overzealous biotech investors. Why just the other day, a certain someone was masterbating to ESPR, trading NORTH OF $110.
Let’s go to the video tape! You’re gonna want to skip to 1:45 for the magic.
Today there are dozens of biotech stocks down more than 5%. It’s an absolute bloodbath–one that was desperately needed. As this sector unwinds, you will be tempted to buy dips. I would advise you to exhibit a modicum of patience and at least wait for the margin liquidations to kick in, which should occur about 3 days from now.
I am not immune to this rout, as I find myself down 1.5% for the session. For a person of ‘extreme caliber’ and penchant for the highest of beta, this is a stroll in the park for me. At this moment in time, I find myself diversified and surprisingly prepared for the death squads that will most assuredly visit the lot of you this week.
I’ve been out all day and haven’t checked my emails or Twitter feed yet. I am sure the Debbie Downers are screaming REDRUM at the top of their black lungs, declaring the market has topped out and all is lost. This is idiot talk. Markets go up and then they go down. We’ve had a really good run in a variety of sectors. The flat YTD broader indices doesn’t tell the whole picture.
Nevertheless, I think you go out and buy quality on dips, free cash flow generating machines, like JNS, MUSA, MD, BABA and SBNY, while avoiding the hot money sectors like biotech and solar. Let The PPT be your guide as to when we are oversold. We’re not there yet.
Comments »


